Reversal Therapeutics Inc.

College Park, MD

UEI
L3M7TYA636C5
CAGE
9MJE2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Black American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4467 Technology Dr, College Park, MD 20742, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Investigating the safety and efficacy of pillararene sulfates as novel and effective reversal agents for both steroidal… R41GM159487 National Institute of General Medical Sciences (NIH) $1,105,101

Quick answers

Is Reversal Therapeutics Inc. registered in SAM.gov?

Yes. Reversal Therapeutics Inc.'s SAM.gov registration is active through July 20, 2027.

What is Reversal Therapeutics Inc.'s most recent federal award?

Reversal Therapeutics Inc.'s most recent federal grant award is Investigating the safety and efficacy of pillararene sulfates as novel and effective reversal agents for both steroidal… (R41GM159487), from National Institute of General Medical Sciences (NIH), on September 12, 2025.

On GovTribe

See Reversal Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login